Adequacy of Management of Patients With Asthma Exacerbation in Martinique

NCT ID: NCT05253391

Last Updated: 2023-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

339 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-10

Study Completion Date

2024-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Asthma is a chronic respiratory disease whose goal of therapeutic, educational and preventive care is to prevent the onset of acute crisis, the most serious of which are life threatening. A general population survey shows a greater prevalence of asthma in the French West Indies compared to hexagonal France, but there is no data to our knowledge on asthma exacerbations requiring pre and intra-hospital emergency services, nor on the clinical severity or on the adequacy of the therapeutic care.

Asthma exacerbations, in particular serious forms requiring immediate admission to the Emergency Department or Intensive Care Unit or leading to hospitalization, can be considered as a failure in the prevention of crisis and therefore disease control. The management of acute or subacute asthma exacerbations is however well codified in expert recommendations, renewed annually by the Global Initiative for Asthma (GINA). These recommendations specify not only the initial care, but also the strategy and modalities of return home and post-emergency follow-up. Recently the French Language Resuscitation Society (SRLF) and the French Society of Emergency Medicine (SFMU) jointly published formalized expert recommendations (RFE) on the management of asthma exacerbations (Le Conte 2019).

These RFEs still remain the benchmark in France for adequate management of asthma exacerbations for adults and children. Despite these updated recommendations, field observations often show inadequate care, both in the emergency and in the post-emergency period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The rationale for this study is based on the lack of data concerning the characteristics of asthma exacerbations and their emergency management in Martinique, but also the lack of awareness of the adequacy of this management according to the stage of severity, as recommended.

Better knowledge of asthma exacerbations, of the stage of clinical severity, of emergency treatments and of post-emergency follow-up, would improve the overall care of asthma patients in Martinique and induce a better control their disease.

This prospective clinical research includes all the services of the Martinique University Hospital which take care of asthma patients during or after their exacerbation: Emergency medical assistance service (SAMU), Mobile emergency and resuscitation structure (SMUR), adult and pediatric emergency services, adult and pediatric resuscitation and pulmonology service.

In order not to guide or influence the therapeutic decisions of the investigators in charge of the patients in this study, and because the evaluation of the adequacy of the management according to the stage of severity is the main objective of the study, no recommendations or instructions are given to the investigators. Each investigator freely decides on the treatment (diagnosis, assessment of severity, treatment, modalities and prescription for discharge from emergencies, hospitalization or not).

This research is the first assessment of asthma exacerbations carried out in our region with the aim of improving their management in order to limit their prognostic impact.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients treated for asthma exacerbation

Routine care

Intervention Type OTHER

The investigator takes care of the patient according to the protocol in force in his department and decides on the final orientation of the patient (transfer to intensive care unit/ICU, hospitalization or home discharge).

No recommendations or instructions are given to the investigators. Each investigator is free to decide on his care and the terms of transfer, hospitalization and discharge.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine care

The investigator takes care of the patient according to the protocol in force in his department and decides on the final orientation of the patient (transfer to intensive care unit/ICU, hospitalization or home discharge).

No recommendations or instructions are given to the investigators. Each investigator is free to decide on his care and the terms of transfer, hospitalization and discharge.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All children and adolescents (2-17 years) and adults (≥ 18 years) asthma patients.
* Supported either by a team from mobile emergency and resuscitation service (SMUR) participating in the study, or by a team from the Emergency Department or possibly admitted directly to an intensive care unit participating in the study.
* With an asthma exacerbation (acute asthma), the diagnostic criteria of which are as follows: history of asthma or wheezing dyspnea, exacerbation of wheezing, difficulty breathing, shortness of breath, wheezing or dry cough, and finally wheezing or silence on auscultation.
* Patient or patient representative who has given oral consent for the use of their medical data for this research.

Exclusion Criteria

* Patient with a strong suspicion or a proven diagnosis of acute respiratory failure on chronic respiratory failure.
* Patient with a strong suspicion or a proven diagnosis of acute left heart failure with wheezing (cardiac asthma) or crackling rales.
* Patient with a strong suspicion or a proven diagnosis of acute febrile pneumonitis.
* Patient with a strong suspicion or a proven diagnosis of acute pleurisy (reduction or elimination of vesicular murmurs, dullness of the bases or imaging).
* Patient or representative of the patient who refused to agree to his participation in the study.
Minimum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Center of Martinique

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU of Martinique - Emergency Department of Pierre Zobda Quitman

Fort-de-France, , Martinique

Site Status RECRUITING

CHU of Martinique - Pediatric Emergency Unit

Fort-de-France, , Martinique

Site Status RECRUITING

CHU of Martinique - Pediatric Resuscitation Unit

Fort-de-France, , Martinique

Site Status RECRUITING

CHU of Martinique - Pneumology Service

Fort-de-France, , Martinique

Site Status RECRUITING

CHU of Martinique - Resuscitation Unit

Fort-de-France, , Martinique

Site Status RECRUITING

CHU of Martinique - SAMU/SMUR

Fort-de-France, , Martinique

Site Status RECRUITING

CHU of Martinique - Emergency Department of Trinité

La Trinité, , Martinique

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Martinique

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Papa GUEYE, MD

Role: CONTACT

05 96 55 20 15 ext. +596

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yannick BROUSTE, MD

Role: primary

05 96 30 64 70 ext. +596

Odile OXYBEL, MD

Role: primary

05 96 55 69 55 ext. +596

Jérôme PIGNOL, MD

Role: primary

05 96 55 31 10 ext. +596

Moustapha AGOSSOU, MD

Role: primary

05 96 55 23 61 ext. +596

Cyrill CHABARTIER, MD

Role: primary

05 96 30 62 94 ext. +596

Papa GUEYE, MD

Role: primary

05 96 55 20 15 ext. +596

Céline MAISONDIEU, MD

Role: primary

05 96 66 46 24 ext. +596

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20_RIPH3-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Asthma in Children
NCT01286532 COMPLETED
Study in Patients With Asthma
NCT00215397 COMPLETED PHASE2
Exercise Training in Asthma
NCT00820716 TERMINATED NA
Self Management Education Asthma
NCT00005712 TERMINATED